PRCT vs RF
Procept Biorobotics Corp (PRCT) versus RF (RF) — a side-by-side from cached financials, not a winner call.
Procept Biorobotics Corp (PRCT) is a medical devices company listed on US.
RF (RF) common stock.
Latest reported PRCT revenue for 2024-12-31 was $224.5M. Net income was -$91.4M. Revenue was up 64.8% from 2023-12-31 to 2024-12-31. PRCT currently screens at market cap $1.52B.
RF does not have a complete income-statement cache yet.
PRCT currently screens at market cap $1.52B. RF currently screens at market cap $0.
Not investment advice. Open the PRCT and RF stock pages for the full models.
Not investment advice.